"

亚游会游戏平台_亚游会游戏平台官方拥有全球最顶尖的原生APP,每天为您提供千场精彩体育赛事,亚游会游戏平台_亚游会游戏平台官方更有真人、彩票、电子老虎机、真人电子竞技游戏等多种娱乐方式选择,亚游会游戏平台_亚游会游戏平台官方让您尽享娱乐、赛事投注等,且无后顾之忧!

                      "

                      专家论坛

                      Expert forum

                      首页 专家论坛 标本专家Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
                      注册

                      Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.

                      2017-12-08 07:46来源:原版作者:Krebs MG

                      INTRODUCTION:

                      Epithelial circulating tumor cells (CTCs) are detectable in patients with non-small cell lung cancer (NSCLC). However, epithelial to mesenchymal transition, a widely reported prerequisite for metastasis, may lead to an underestimation of CTC number. We compared directly an epithelial marker-dependent (CellSearch) and a marker-independent (isolation by size of epithelial tumor cells [ISET]) technology platform for the ability to identify CTCs. Molecular characteristics of CTCs were also explored.

                      METHODS:

                      Paired peripheral blood samples were collected from 40 chemon?ive, stages IIIA to IV NSCLC patients. CTCs were enumerated by Epithelial Cell Adhesion Molecule-based immunomagnetic capture (CellSearch, Veridex) and by filtration (ISET, RareCell Diagnostics). CTCs isolated by filtration were assessed by immunohistochemistry for epithelial marker expression (cytokeratins, Epithelial Cell Adhesion Molecule, epidermal growth factor receptor) and for proliferation status (Ki67).

                      RESULTS:

                      CTCs were detected using ISET in 32 of 40 (80%) patients compared with 9 of 40 (23%) patients using CellSearch. A subpopulation of CTCs isolated by ISET did not express epithelial markers. Circulating tumor microemboli (CTM, clusters of ≥ 3 CTCs) were observed in 43% patients using ISET but were undetectable by CellSearch. Up to 62% of single CTCs were positive for the proliferation marker Ki67, whereas cells within CTM were nonproliferative.

                      CONCLUSIONS:

                      Both technology platforms detected NSCLC CTCs. ISET detected higher numbers of CTCs including epithelial marker negative tumor cells. ISET also isolated CTM and permitted molecular characterization. Combined with our previous CellSearch data confirming CTC number as an independent prognostic biomarker for NSCLC, we propose that this complementary dual technology approach to CTC analysis allows more complete exploration of CTCs in patients with NSCLC.

                      版权声明:

                      本网站所有注明“来源:“阳普医疗”的文字、图片和音视频资料,版权均属于阳普医疗所有,非经授权,任何媒体、网站或个人不得转载,授权转载时须注明

                      “来源:阳普医疗”。本网所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。

                      网友评论:

                      亚游会游戏平台_亚游会游戏平台官方